Tower Bridge Advisors Abbott Laboratories Transaction History

Tower Bridge Advisors

$939 Billion
Q4 2024

A detailed history of Tower Bridge Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Tower Bridge Advisors holds 45,035 shares of ABT stock, worth $5.75 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

45,035

Previous 45,017 0.04%

Holding current value

$5.75 Million

Previous $5.13 Billion 0.75%

% of portfolio

0.54%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$111.93 - $119.39 $2,014 - $2,149	18 Added 0.04%	45,035 $5.09 Billion
Q3 2024 Nov 06, 2024	BUY	$100.07 - $118.13 $159,811 - $188,653	1,597 Added 3.68%	45,017 $5.13 Billion
Q2 2024 Jul 24, 2024	SELL	$100.73 - $112.44 $89,951 - $100,408	-893 Reduced 2.02%	43,420 $4.51 Billion
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $3,833 - $4,233	-35 Reduced 0.08%	44,313 $5.04 Billion
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $104,890 - $128,395	-1,163 Reduced 2.56%	44,348 $4.88 Billion
Q3 2023 Nov 01, 2023	BUY	$95.53 - $114.62 $322,604 - $387,071	3,377 Added 8.01%	45,511 $4.41 Billion
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $1.86 Million - $2.07 Million	-18,471 Reduced 30.48%	42,134 $4.59 Billion
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $87,755 - $103,293	-906 Reduced 1.47%	60,605 $6.14 Billion
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $26,616 - $31,225	-280 Reduced 0.45%	61,511 $6.75 Billion
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $45,283 - $52,430	468 Added 0.76%	61,791 $5.98 Billion
Q2 2022 Jul 21, 2022	BUY	$102.07 - $123.37 $94,210 - $113,870	923 Added 1.53%	61,323 $6.66 Billion
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $52,449 - $63,958	-460 Reduced 0.76%	60,400 $7.15 Billion
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $35,814 - $43,852	310 Added 0.51%	60,860 $8.57 Billion
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $120,626 - $133,448	1,034 Added 1.74%	60,550 $7.15 Billion
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $376,612 - $443,326	3,560 Added 6.36%	59,516 $6.9 Billion
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $250,005 - $294,544	2,297 Added 4.28%	55,956 $6.71 Billion
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $1.97 Million - $2.14 Million	18,739 Added 53.66%	53,659 $5.88 Billion
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $6,231 - $7,567	68 Added 0.2%	34,920 $3.8 Billion
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $18,376 - $23,520	-240 Reduced 0.68%	34,852 $3.19 Billion
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $60,935 - $89,104	970 Added 2.84%	35,092 $2.77 Billion
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $145,714 - $162,214	1,856 Added 5.75%	34,122 $2.96 Billion
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $379,328 - $411,309	-4,635 Reduced 12.56%	32,266 $2.7 Billion
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $36,440 - $42,500	-500 Reduced 1.34%	36,901 $3.1 Billion
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $351,598 - $398,310	-5,363 Reduced 12.54%	37,401 $2.71 Billion
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $36,486 - $44,016	-600 Reduced 1.38%	42,764 $3.14 Billion
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $7,196 - $7,942	125 Added 0.29%	43,364 $2.64 Billion
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $41,583 - $47,015	-739 Reduced 1.68%	43,239 $2.59 Billion
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $2,093 - $2,241	39 Added 0.09%	43,978 $2.51 Billion
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $2.11 Million - $2.36 Million	43,939	43,939 $2.34 Billion

Others Institutions Holding ABT

# of Institutions

3,375

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Abbott Laboratories Transaction History